Literature DB >> 24021292

Liquid dosage forms extemporaneously prepared from commercially available products - considering new evidence on stability.

Alison Haywood1, Beverley D Glass.   

Abstract

Although the world's population is ageing and as a result of this an increasing number of patients are experiencing difficulty in swallowing, there remains a lack of commercially available oral liquids for both these older and paediatric patients. This presents a problem to health care professionals, especially the pharmacist in practice, who is often required to provide a solution for these patients by preparing oral liquids extemporaneously from commercially available products. Preparation of these oral liquids is challenging, both due to the lack of pharmacopoeial and stability-indicating formulae and the fact that their stability is not only determined by the active pharmaceutical ingredient, but also the ability of excipients from the commercial product to interact with each other and the active pharmaceutical ingredient. This increases the complexity of the stability considerations to be taken into account within these oral liquids, highlighting the number of parameters to be considered in the extemporaneous preparation of oral liquids. This paper presents new evidence on the stability of 42 oral liquids prepared from commercially available products, reported on in the literature since the previous review published in 2006. However, unlike the previous review where the stability concerns in 7.2% of the extemporaneously prepared oral liquids were mainly due to interaction between the active pharmaceutical ingredients and the excipients in the commercial product, most of these stability considerations have been recognised and this has resulted in the authors proposing solutions to these problems prior to the extemporaneous preparation of the oral liquid. As such this paper also focuses on the increased level of research that has been undertaken to solve previous issues related to stability, especially in terms of the use of commercial products, which is common practice in the extemporaneous preparation of oral liquids.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24021292     DOI: 10.18433/j38887

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  6 in total

1.  Problems with oral formulations prescribed to children: a focus group study of healthcare professionals.

Authors:  Rebecca Venables; Heather Stirling; Hannah Batchelor; John Marriott
Journal:  Int J Clin Pharm       Date:  2015-07-15

2.  Limited Influence of Excipients in Extemporaneous Compounded Suspensions.

Authors:  Eli Dijkers; Valerie Nanhekhan; Astrid Thorissen; Diego Marro; Marta Uriel
Journal:  Hosp Pharm       Date:  2017-07-13

3.  A Critical Assessment of Extemporaneous Formulations for Proton Pump Inhibitors: The Importance of Proper Vehicle Selection.

Authors:  Ognjenka Rahić; Jasmina Hadžiabdić; Amina Tucak; Merima Sirbubalo; Lamija Hindija; Alisa Elezović; Edina Vranić
Journal:  J Pediatr Pharmacol Ther       Date:  2022-09-26

4.  Stability of extemporaneously prepared sitagliptin phosphate solution.

Authors:  Abdel Naser Zaid; Yara Abu Zaaror; Aiman Kaddumi; Mashhour Ghanem; Nidal Jaradat; Tharaa Abu Salah; Sameera Siaj; Lana Omari
Journal:  PLoS One       Date:  2022-03-16       Impact factor: 3.240

5.  Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study.

Authors:  Charles Bavouma Sombié; J E Kéré Guetambaba; Hermine Zimé Diawara; Josias Yaméogo; Salfo Ouédraogo; Jonathan Goole; Rasmané Semdé
Journal:  J Adv Pharm Technol Res       Date:  2022-04-07

6.  Providing Suitable Pediatric Formulations for Canadian Children: A Call for Action.

Authors:  Catherine Litalien; Julie Autmizguine; Antoine Carli; Denis Giroux; Denis Lebel; Jean-Marie Leclerc; Yves Théorêt; Andrea Gilpin; Sophie Bérubé
Journal:  Can J Hosp Pharm       Date:  2020-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.